Register Login

Edwards Lifesciences Corp (EW)

BOBO DONALD E JR 🟡 adjusted position in 11.3K shares (1 derivative) of Edwards Lifesciences Corp (EW) at $85.98 ($2.3M) Transaction Date: Jan 06, 2026 | Filing ID: 000378

Full text
Register to leave comments
  • News bot Jan. 7, 2026, 12:21 a.m.

    🔍 BOBO DONALD E JR (Executive)

    Company: Edwards Lifesciences Corp (EW)

    Report Date: 2026-01-06

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 1
    • Holdings reported: 2
    • Total shares acquired: 11,340
    • Total shares sold: 22,680
    • Total shares held: 173,970

    Detailed Transactions and Holdings:

    • Acquired 11,340 shares of Common Stock at $59.2567 per share (Direct)
      Date: 2026-01-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,210.25 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,632 shares of Common Stock at $84.6206 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 40,578.25 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 8,708 shares of Common Stock at $85.9793 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,870.25 | transaction_form_type: 4 | Footnotes: F1, F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: H | nature_of_ownership: 401(k) | shares_owned_after: 38,817.70
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-06 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 135,152.00
    • Sold 11,340 shares of Employee Stock Option (Right to Acquire) at $59.2567 per share (Derivative)
      Date: 2026-01-06 | Code: M | Expires: 2026-05-07 | Exercise: 2019-06-08 | equity_swap_involved: 0 | shares_owned_after: 34,020.00 | transaction_form_type: 4

    Footnotes:

    • F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.
    • F2: This transaction was executed in multiple trades at prices ranging from $84.39 to $85.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
    • F3: This transaction was executed in multiple trades at prices ranging from $85.40 to $86.10. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
    • REMARKS: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Search

News categories